Search results for "Anticoagulation"
Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19
A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
https://immattersacp.org/weekly/archives/2021/08/10/1.htm
10 Aug 2021
Anticoagulation not superior to placebo for calf DVT in low-risk patients, may increase bleeding risk
The randomized, double-blind, placebo-controlled trial examined a composite measure of extension of calf deep venous thrombosis (DVT) to proximal veins, contralateral proximal DVT, and symptomatic pulmonary embolism in a modified intention-to-treat population.
https://immattersacp.org/weekly/archives/2016/11/15/6.htm
15 Nov 2016
New oral anticoagulants may slightly decrease all-cause mortality when compared to warfarin, meta-analysis suggests
In patients with atrial fibrillation, the advantages of all 4 new oral anticoagulants over warfarin seem to outweigh the risks, a new meta-analysis found.
https://immattersacp.org/weekly/archives/2013/12/10/6.htm
10 Dec 2013
Guidance released on use of new oral anticoagulants in nonvalvular afib
The European Heart Rhythm Association published guidance last week on using new oral anticoagulants in patients with nonvalvular atrial fibrillation.
https://immattersacp.org/weekly/archives/2013/05/07/6.htm
7 May 2013
NSAIDs may increase bleeding, CV events when combined with antiplatelet or anticoagulant agents post-MI
Nonsteroidal anti-inflammatory drugs (NSAIDs) were associated with increased risk of bleeding and thrombotic events, even during short-term treatment, among patients receiving antithrombotic therapy after myocardial infarction (MI), a study found.
https://immattersacp.org/weekly/archives/2015/03/03/2.htm
3 Mar 2015
Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://immattersacp.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023
New afib guideline covers novel anticoagulants, ablation
A new guideline for managing nonvalvular atrial fibrillation recommends using a more comprehensive risk calculator, diminishing aspirin's role, adding 3 new anticoagulants to treatment options, and increasing use of radiofrequency ablation.
https://immattersacp.org/weekly/archives/2014/04/01/4.htm
1 Apr 2014
Adding aspirin or NSAID to anticoagulant doubles bleeding risk
Taking aspirin or an NSAID while on anticoagulant therapy significantly increases the risk of bleeding in patients who have had a venous thromboembolism (VTE), a recent study found.
https://immattersacp.org/weekly/archives/2014/04/22/5.htm
22 Apr 2014
Tailoring anticoagulation more of a reality with DOACs
Direct oral anticoagulants have the potential to replace warfarin for the treatment of many patients with venous thromboembolism, but without a need for routine monitoring, good patient selection is key to their use.
https://immattersacp.org/archives/2018/03/tailoring-anticoagulation-more-of-a-reality-with-doacs.htm
1 Mar 2018
Higher CHADS2 scores can indicate higher risk in patients on anticoagulants
Higher CHADS2 scores pointed to higher risk for adverse outcomes, including stroke, bleeding and death, in patients with atrial fibrillation receiving anticoagulation, according to a new study.
https://immattersacp.org/weekly/archives/2011/11/15/5.htm
15 Nov 2011